Iasella, M.P.; Ruttens, D.; Hompes, D.; Vandecaveye, V.; Sciot, R.; Deroose, C.; Douchy, T.; Decramer, T.; Jacobs, S.; Denayer, E.;
et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306.
https://doi.org/10.3390/cancers17081306
AMA Style
Iasella MP, Ruttens D, Hompes D, Vandecaveye V, Sciot R, Deroose C, Douchy T, Decramer T, Jacobs S, Denayer E,
et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers. 2025; 17(8):1306.
https://doi.org/10.3390/cancers17081306
Chicago/Turabian Style
Iasella, Maria Pia, Dries Ruttens, Daphne Hompes, Vincent Vandecaveye, Raf Sciot, Christophe Deroose, Thomas Douchy, Thomas Decramer, Sandra Jacobs, Ellen Denayer,
and et al. 2025. "Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour" Cancers 17, no. 8: 1306.
https://doi.org/10.3390/cancers17081306
APA Style
Iasella, M. P., Ruttens, D., Hompes, D., Vandecaveye, V., Sciot, R., Deroose, C., Douchy, T., Decramer, T., Jacobs, S., Denayer, E., Van Calenbergh, F., Legius, E., & Brems, H.
(2025). Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers, 17(8), 1306.
https://doi.org/10.3390/cancers17081306
